Effexor and Taclonex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Effexor (venlafaxine hydrochloride) and Taclonex (betamethasone dipropionate; calcipotriene hydrate). Common drug interactions include hepatic enzyme increased among females and feeling of despair among males.

The phase IV clinical study analyzes what interactions people have when they take Effexor and Taclonex. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

What is Taclonex?

Taclonex has active ingredients of betamethasone dipropionate; calcipotriene hydrate. It is often used in psoriasis. eHealthMe is studying from 1,618 Taclonex users. Check the latest studies of Taclonex.



On Jul, 31, 2026

22 people who take Effexor and Taclonex together, and have interactions are studied.

Effexor and Taclonex drug interactions.

What are the common drug interactions of Effexor and Taclonex, by gender? *:

female:

  1. Hepatic enzyme increased
  2. Joint swelling
  3. Local swelling (swelling at the site of some application of substance or injury)
  4. Nausea (feeling of having an urge to vomit)
  5. Rash
  6. Vertigo
  7. Cushingoid (obesity and weakening of the muscles)
  8. Delirium (wild excitement)
  9. Fall
  10. Intervertebral disc protrusion (spinal disc protrusion)

male:

  1. Feeling of despair
  2. Suicidal ideation
  3. Therapeutic response unexpected

What are the common drug interactions of Effexor and Taclonex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Nausea (feeling of having an urge to vomit)

30-39:

  1. Therapeutic response decreased (less preventive response)

40-49:

  1. Cushingoid (obesity and weakening of the muscles)
  2. Fatigue (feeling of tiredness)
  3. Intervertebral disc protrusion (spinal disc protrusion)
  4. Lipohypertrophy (a lump under the skin caused by accumulation of extra fat at the site of many subcutaneous injections of insulin)
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Weight increased
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  9. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  10. Polyuria (production of too much dilute urine)

50-59:

  1. Headache (pain in head)
  2. Back pain
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Gout (uric acid crystals building up in the body)
  6. Hepatic enzyme increased
  7. Joint swelling
  8. Local swelling (swelling at the site of some application of substance or injury)
  9. Rash
  10. Vertigo

60+:

  1. Pain
  2. Abasia (inability to walk)
  3. Hypersensitivity
  4. Injection site haemorrhage (bleeding from injection site)
  5. Ligament sprain (ligament stretched)
  6. Nausea (feeling of having an urge to vomit)
  7. Nerve compression
  8. Panic attack
  9. Poor quality sleep
  10. Sinus disorder (disease of sinus)

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 27.27%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 22.73%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 13.64%
  4. High Blood Cholesterol: 3 people, 13.64%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 13.64%
  6. Stress And Anxiety: 2 people, 9.09%
  7. Sleep Disorder: 2 people, 9.09%
  8. Rosacea (a skin condition that causes facial redness): 2 people, 9.09%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.09%
  10. Pain: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and Taclonex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Effexor and Taclonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Taclonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Taclonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride and betamethasone dipropionate; calcipotriene hydrate (the active ingredients of Effexor and Taclonex, respectively), and Effexor and Taclonex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: